Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
claudia.worth@ndorms.ox.ac.uk

Claudia Worth

Senior Clinical Research Fellow in Rheumatology

Recent publications

Granulocyte-macrophage colony-stimulating factor neutralisation in patients with axial spondyloarthritis in the UK (NAMASTE): a randomised, double-blind, placebo-controlled, phase 2 trial.

Worth C. et al, (2024), Lancet Rheumatol, 6, e537 - e545

Humoral immune response after COVID-19 infection or BNT162b2 vaccine among older adults: evolution over time and protective thresholds.

Meyer M. et al, (2022), Geroscience, 44, 1229 - 1240

Novel Therapeutic Targets in Axial Spondyloarthritis.

Worth C. et al, (2018), Curr Treatm Opt Rheumatol, 4, 174 - 182

An audit of the use of hydroxychloroquine in rheumatology clinics.

Worth C. et al, (2018), Rheumatol Adv Pract, 2

More publications